Tuberculosis after anti-TNF therapy: a continuous learning process
Authors:
- 28 May 2012
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 41 (5) , 401-403
Abstract
(2012). Tuberculosis after anti-TNF therapy: a continuous learning process. Scandinavian Journal of Rheumatology: Vol. 41, No. 5, pp. 401-403. doi: 10.3109/03009742.2012.676063Keywords
This publication has 7 references indexed in Scilit:
- Adalimumab Treatment of Life‐Threatening TuberculosisClinical Infectious Diseases, 2009
- Mycobacterial and Other Serious Infections in Patients Receiving Anti–Tumor Necrosis Factor and Other Newly Approved Biologic Therapies: Case Finding through the Emerging Infections NetworkClinical Infectious Diseases, 2008
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- A Patient with De Novo Tuberculosis during Anti-Tumor Necrosis Factor-- Therapy Illustrating Diagnostic Pitfalls and Paradoxical Response to TreatmentClinical Infectious Diseases, 2007
- Delayed response to anti-tuberculosis treatment in a patient on infliximabRespiratory Medicine, 2005
- Paradoxical Response to Antituberculous Therapy in Infliximab-Treated Patients with Disseminated TuberculosisClinical Infectious Diseases, 2005